Total Payments
$10,207
2024 Payments
$3,093
Companies
42
Transactions
434
Medicare Patients
2,716
Medicare Billing
$312,443
Payment Breakdown by Category
Food & Beverage$9,990 (97.9%)
Education$216.39 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,990 | 431 | 97.9% |
| Education | $216.39 | 3 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,780 | 104 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,031 | 66 | $0 (2024) |
| Janssen Biotech, Inc. | $962.49 | 40 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $652.13 | 25 | $0 (2024) |
| Boston Scientific Corporation | $478.07 | 5 | $0 (2023) |
| Celgene Corporation | $444.46 | 47 | $0 (2024) |
| Ardelyx, Inc. | $428.05 | 17 | $0 (2024) |
| PFIZER INC. | $417.41 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $357.21 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $337.39 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,093 | 135 | ABBVIE INC. ($554.14) |
| 2023 | $2,127 | 120 | ABBVIE INC. ($529.64) |
| 2022 | $1,693 | 61 | ABBVIE INC. ($287.66) |
| 2021 | $703.22 | 25 | Janssen Biotech, Inc. ($224.66) |
| 2020 | $471.13 | 28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($196.96) |
| 2019 | $1,119 | 23 | Boston Scientific Corporation ($226.28) |
| 2018 | $551.44 | 20 | Janssen Scientific Affairs, LLC ($231.23) |
| 2017 | $449.14 | 22 | Janssen Scientific Affairs, LLC ($105.30) |
All Payment Transactions
434 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $38.88 | General |
| Category: LIVER DISEASE | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $105.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $217.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $138.60 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $43.02 | General |
| Category: Immunology | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/11/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $39.88 | General |
| Category: GI COLON PREP | ||||||
| 11/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.98 | General |
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Immunology | ||||||
| 10/29/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Immunology | ||||||
| 10/28/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.49 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 568 | 670 | $460,927 | $73,926 |
| 2022 | 9 | 727 | 854 | $521,298 | $86,351 |
| 2021 | 11 | 769 | 858 | $589,666 | $89,100 |
| 2020 | 9 | 652 | 745 | $220,431 | $63,066 |
Total Patients
2,716
Total Services
3,127
Medicare Billing
$312,443
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 306 | $106,488 | $28,078 | 26.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 58 | 58 | $82,708 | $12,577 | 15.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 66 | 66 | $77,278 | $5,959 | 7.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 63 | 63 | $94,343 | $5,414 | 5.7% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 11 | 11 | $14,773 | $4,435 | 30.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 22 | 22 | $24,036 | $4,167 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 62 | $14,694 | $3,743 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $15,718 | $3,061 | 19.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $13,344 | $2,227 | 16.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $10,740 | $2,183 | 20.3% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 11 | 11 | $6,805 | $2,082 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 366 | $127,368 | $34,626 | 27.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 69 | 69 | $98,394 | $14,449 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $41,734 | $9,690 | 23.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 86 | 87 | $97,788 | $7,696 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 111 | $26,307 | $6,917 | 26.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 67 | 68 | $91,481 | $5,700 | 6.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $15,752 | $3,559 | 22.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 18 | 18 | $19,044 | $3,311 | 17.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $3,430 | $405.19 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 208 | 287 | $99,876 | $27,901 | 27.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 76 | 77 | $109,802 | $16,107 | 14.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 104 | 104 | $139,672 | $9,644 | 6.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 109 | 109 | $122,516 | $9,088 | 7.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 64 | 64 | $34,688 | $8,238 | 23.7% |
About Atul Marathe
Atul Marathe is a Gastroenterology healthcare provider based in Woodbridge, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326034695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Atul Marathe has received a total of $10,207 in payments from pharmaceutical and medical device companies, with $3,093 received in 2024. These payments were reported across 434 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,990).
As a Medicare-enrolled provider, Marathe has provided services to 2,716 Medicare beneficiaries, totaling 3,127 services with total Medicare billing of $312,443. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Woodbridge, VA
- Active Since 09/22/2005
- Last Updated 02/13/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1326034695
Products in Payments
- STELARA (Biological) $928.72
- ZEPOSIA (Drug) $677.83
- RINVOQ (Biological) $614.57
- XIFAXAN (Drug) $581.75
- ENTYVIO (Biological) $504.12
- IBSRELA (Drug) $428.05
- XELJANZ (Drug) $355.80
- DUPIXENT (Biological) $350.17
- VOQUEZNA (Drug) $337.39
- SKYRIZI (Biological) $302.12
- TREMFYA (Drug) $298.72
- LINZESS (Drug) $194.28
- GI GENIUS (Device) $190.38
- OMVOH (Drug) $189.78
- TRULANCE (Drug) $184.61
- Diamondback Peripheral (Device) $176.00
- CREON (Drug) $172.04
- SUFLAVE (Drug) $148.53
- GENERAL ENDOCHOICE (Device) $138.58
- ORISE (Device) $137.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Woodbridge
Dr. Kenneth Josovitz, M.d, M.D
Gastroenterology — Payments: $112,728
Gastroenterology $112,728
Dr. Jack Huang, M.d, M.D
Gastroenterology — Payments: $73,321
Gastroenterology $73,321
Dr. Michael Brown, M.d, M.D
Gastroenterology — Payments: $20,342
Gastroenterology $20,342
Ali Kazemi, M.d, M.D
Gastroenterology — Payments: $9,618
Gastroenterology $9,618
Mohammad Razavi, Md, MD
Gastroenterology — Payments: $7,205
Gastroenterology $7,205
Anisha Thadani, Md, MD
Gastroenterology — Payments: $5,292
Gastroenterology $5,292